Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 636.60M | £ 787.70M | £ 1.42B | £ 776.00M | £ 1.44B |
Total Assets | £ 4.37B | £ 3.83B | £ 4.86B | £ 8.29B | £ 8.68B |
Total Debt | £ 2.11B | £ 1.41B | £ 1.59B | £ 3.82B | £ 4.42B |
Net Debt | £ 1.48B | £ 626.10M | £ 170.50M | £ 3.04B | £ 2.98B |
Total Liabilities | £ 3.61B | £ 2.95B | £ 3.66B | £ 7.14B | £ 7.67B |
Stockholders Equity | £ 747.80M | £ 876.60M | £ 1.22B | £ 1.18B | £ 1.04B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |